Elkady Fathy M, Badr Bahaa M, Hashem Amr H, Abdulrahman Mohammed S, Abdelaziz Amer M, Al-Askar Abdulaziz A, AbdElgayed Gehad, Hashem Hany R
Department of Microbiology and Immunology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
Department of Basic Medical and Dental Sciences, Faculty of Dentistry, Zarqa University, Zarqa, Jordan.
Front Microbiol. 2024 Oct 3;15:1454623. doi: 10.3389/fmicb.2024.1454623. eCollection 2024.
Commonly used antimicrobial agents are no longer effective due to their overuse or misuse. In addition, many medicinal plant extracts can combat infectious diseases due to their main active constituents or secondary metabolites. The current study aimed to assess the bioactivities of (LN) leaf extract (LE) against different multi-drug resistant (MDR) () isolates. The ethyl acetate extract of a (LN) leaf was analyzed using GC-MS, which identified 27 key bioactive compounds. The major constituents found were as follows: 7-acetyl-6-ethyl-1,1,4,4-tetramethyltetralin, isopropyl myristate, thiocarbamic acid, N,N-dimethyl, S-1,3-diphenyl-2-butenyl ester, hahnfett, cyclopentane acetic acid, 3-oxo-2-pentyl-, methyl ester, hexadecanoic acid, and dotriacontane. Our study demonstrated that the LN leaf was a rich source of other important phytochemicals, including phenolic acids, tannins, saponins, and steroids. The relative biosafety of the LE was determined from the elevated inhibitory concentration 50 (IC50) of 262 μg/mL, as calculated from the cytotoxicity assay against the Wi-38 normal cell line. Conversely, 12.7 and 24.5 μg/mL were the recorded low IC50 values for the tested extract against the MCF-7 and Hep-G2 cancerous cell lines, respectively, reflecting its potent activity against the tested cancerous cell lines. Microbiologically, the susceptible isolates to the tested extract showed a growth inhibition zone diameter, in the well diffusion assay, ranging from 11.34 ± 0.47 to 26.67 ± 0.47 mm, and a percent inhibition (PI) value of 50-106.2%, reflecting its acceptable activity. In addition, the broth microdilution assay recorded minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) in the ranges of 15.625-1,000 μg/mL and 125-1,000 μg/mL, respectively. In conclusion, the LE revealed showed promising activity and high selectivity against . Moreover, the extract exhibited natural anticancer activities with safe low concentrations, indicating its potential as a superior candidate for future studies of its active constituents.
由于常用抗菌剂的过度使用或滥用,它们已不再有效。此外,许多药用植物提取物因其主要活性成分或次生代谢产物而能够对抗传染病。本研究旨在评估(LN)叶提取物(LE)对不同多重耐药(MDR)()分离株的生物活性。使用气相色谱 - 质谱联用仪(GC - MS)分析了(LN)叶的乙酸乙酯提取物,鉴定出27种关键生物活性化合物。发现的主要成分如下:7 - 乙酰基 - 6 - 乙基 - 1,1,4,4 - 四甲基四氢化萘、肉豆蔻酸异丙酯、硫代氨基甲酸、N,N - 二甲基、S - 1,3 - 二苯基 - 2 - 丁烯基酯、哈恩费特、环戊烷乙酸、3 - 氧代 - 2 - 戊基 - 甲酯、十六烷酸和三十二烷。我们的研究表明,LN叶富含其他重要的植物化学物质,包括酚酸、单宁、皂苷和类固醇。通过针对Wi - 38正常细胞系的细胞毒性试验计算得出,LE的半数抑制浓度(IC50)升高至262μg/mL,由此确定了LE的相对生物安全性。相反,针对MCF - 7和Hep - G2癌细胞系,测试提取物的IC50值分别记录为12.7和24.5μg/mL,这反映了其对测试癌细胞系的强效活性。在微生物学方面,在药敏试验中,对测试提取物敏感的()分离株的生长抑制圈直径范围为11.34±0.47至26.67±0.47mm,抑制率(PI)值为50 - 106.2%,这反映了其可接受的活性。此外,肉汤微量稀释法记录的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)范围分别为15.625 - 1,000μg/mL和125 - 1,000μg/mL。总之,()LE显示出对()有前景的活性和高选择性。此外,该提取物在低浓度下具有天然抗癌活性且安全性良好,表明其作为未来活性成分研究的优秀候选物具有潜力。